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Summary 
Plasma cells represent the final stage of B lymphocyte differentiation. Most plasma cells in sec- 
ondary lymphoid tissues live for a few days, whereas those in the lamina propria ofmucosa and 
in bone marrow live for several weeks. To investigate the regulation of human plasma cell sur- 
vival, plasma cells were isolated from tonsils according to high CD38 and low CD20 expres- 
sion. Tonsillar plasma cells express CD9, CD19, CD24, CD37,  CD40, CD74, and HLA-DR, 
but not CD10, HLA-DQ, CD28, CD56, and Fas/CD95. Although plasma cells express intra- 
cytoplasmic Bcl-2, they undergo swift apoptosis in vitro and do not respond to CD40 trigger- 
ing.  Bone marrow fibroblasts and rheumatoid synoviocytes, however, prevented plasma cells 
from undergoing apoptosis in a contact-dependent fashion. These data indicate that fibroblasts 
may form a microenvironment favorable for plasma cell survival under normal and pathological 
conditions. 
O 
ne of the most striking facts of the immune system is 
the presence of several milligrams of Ig (antibody) in 
every  milliliter  of human  blood,  which  represents  1016 
molecules displaying  10  9 different specificities.  Antibodies 
are secreted by plasma cells at a rate of 10 3 antibody mole- 
cules/cell per s (1, 2).  Plasma cells represent the final differ- 
entiation  stage of B  lymphocytes after they have encoun- 
tered  antigens  and  interacted  with  various  cell  types 
through both membrane molecules and cytokines (for re- 
view  see  reference  3).  To  avoid overproduction  of anti- 
bodies,  the  number  of plasma cells  in  the  body must  be 
tightly controlled. Two basic strategies have evolved within 
the immune system to control plasma cell number: (a) dur- 
ing  humoral  immune  responses,  not  all  activated  B  cells 
undergo  terminal  differentiation  into  antibody-secreting 
plasma cells,  as many of them differentiate into memory B 
cells (4); and (b) the life span of plasma cells is tightly regu- 
lated.  It has been shown that plasma cells generated during 
primary  humoral  immune  responses  are  mainly  located 
within  the  medullary cords  of lymph nodes  or in the  red 
pulp of the spleen and have a life span of only a few days (5, 
6).  During  secondary  humoral  immune  responses,  how- 
ever,  some  generated  plasma  cells  will  migrate  from  the 
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secondary lymphoid tissues into the bone marrow (BM) I or 
into the lamina propria of mucosa (7),  where they survive 
and secrete large amounts of antibodies for at least 3 wk (5). 
Understanding the physiology of normal plasma cell sur- 
vival represents an important  question  for both basic  im- 
munology and for pathophysiology of malignant myeloma 
and  plasmacytoma. Although  plasma  cells  have  a  distinct 
morphology, it has been difficult to isolate them from pe- 
ripheral lymphoid tissues because of the lack of specific sur- 
face markers and their low frequency. After having isolated 
human B  cell subsets representing naive B  cells,  germinal 
center (GC) B cells and memory B cells from tonsils  (8-10), 
we  examined the  isolation and  characterization  of plasma 
cells  (PC), the end point of B cell differentiation. The iso- 
lation was based on the observation that human plasma cells 
express high levels of CD38  and low levels of CD20  (11- 
13).  As  reported  herein,  human  tonsillar  plasma  cells, 
which  express intracellular Bcl-2 protein  and lack surface 
Fas/CD95,  die  rapidly by apoptosis,  a  phenomenon  that 
could not be prevented by antigen receptor or CD40 trig- 
lAbbreviations used in this paper: BM, bone marrow; GC, germinal center; 
PC, plasma  cells; SAC, Staphylococcus  aureus strain Cowan I; TdT, terminal 
deoxynucleotidyl transferase;  TUNEL, TdT-mediated  dUTP-FITC nick 
end labeling. 
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when cultured in contact with bone marrow fibroblasts. 
Materials and Methods 
Antibodies  and Reagents.  The mouse n~kbs  used for the phe- 
notypic  studies  were  purchased  from  the  following  sources: 
FITC-conjugated  anti-CD3  (IOT3),  anti-CD19  (IOB4),  anti- 
CD20  (IOB20),  anti-CD37  (IOB1),  anti-Fas  (UB2),  unconju- 
gated  anti-CD9  (IOB2),  and  biotinylated  anti-CD24  (IOB3) 
(Immunotech,  Marseille,  France);  FITC-conjugated  anti-CD10 
(Calla),  anti-CD14  (Leu  M3),  anti-HLA-DR.,  anti-HLA-DQ, 
and  PE-conjugated  anti-CD38  (Leu  17)  (Becton  Dickinson 
Monoclonal  Center,  Mountain  View,  CA);  FITC-conjugated 
anti-CD28  (CLB,  Amsterdam,  The  Netherlands);  FITC-conju- 
gated anti-Bcl-2 (Dako,  Glostrup, Denmark); unconjugated anti- 
CD56  (Coulter  Immunology,  Hialeah,  FL);  unconjugated  anti- 
CD74 (BU45) (Binding Site, Birmingham, UK). FITC-conjugated 
anti-CD40  (mAb  89)  was  produced  in  the  laboratory,  as  previ- 
ously described (14).  Anti-IL-6 receptor gp80-blocking antibody 
BR6  (Innotest,  Besanqon,  France)  was used at  10  mg/ml.  Anti- 
CD40  mAb  used  for  cultures  (G28.5)  was  kindly  provided by 
Dr.  E.  Clark  (University" of Washington,  Seattle, WA)  (15).  For 
ELISA, alkaline phosphatase-conjugated  rabbit anti-IgA and anti- 
lgG  antibodies  were  from  Dako  and  anti-lgM  antibody  from 
Biosys  (Compi~gne,  France).  Formalinized particles  of Staph},lo- 
coccus aureus strain  Cowan  I  (SAC)  were  from  Calbiochem- 
Behring Corp.  (La Jolla, CA) and were used at 0.05%. 
TNF-~x was purchased  from Genzyme (Cambridge,  MA)  and 
was used at a final concentration of 2.5 ng/ml. IL-2 (Amgen Bio- 
logicals, Thousand  Oaks,  CA) was used at  10  U/nil. IL-3,  IL-4, 
1L-6,  and  IL-10  (all  from  Schering-Plough  Research  Institute, 
Kenilworth, NJ) were used at 10 ng/n-Ll, 50 U/ml, 40 ng/ml, and 
100  ng/iM, respectively. 
Isolation of Plasma  Cells from  Tonsils.  Total tonsillar  cell sus- 
pension was obtained by dilacerating tonsils with tweezers and di- 
gesting the remaining tissue twice with 1 mg/ml collagenase and 
0.1  U/ml  DNase  (both  from  Sigma  Chemical  Co.,  St.  Louis, 
MO) in tLPMI-1640 (GIBCO BRL, Gaithersburg, MD) at 37~ 
for  20  rain.  To  remove small  cells  (red  cells and  small  resting 
cells),  the cellular suspension  was centrifuged three or four times 
(10g, 20 rain, 4~  on PBS 1.5% BSA (Miles Inc., Kankakee, IL). 
Plasma cells were enriched in the pellet.  Cells were then labeled 
at  4~  with  PE-conjugated  anti-CD38  mAb  either alone  or in 
combination  with  FITC-conjugated  anti-CD20  mAb.  PC,  to- 
gether  with  GC  and  resting  B  ceils  used  as  comparison,  were 
sorted with a FACStar Plus  |  (Becton Dickinson &  Co.,  Sunny- 
vale, CA) equipped with a 4-W argon laser.  Sorting was carried 
out at 4~ 
Flow  Cytometric Analysis.  Phenotypic  analysis  of plasma  cells 
was perfomaed by immunofluorescence flow cytometry on sorted 
CD38 high PC  (stained  with anti-CD38-PE),  using  either mouse 
mAbs  conjugated  with  FITC  or  biotinylated  or  unconjugated 
mouse  mAbs  followed  by  FITC-conjugated  sheep  anti-mouse 
1gF(ab)'2  or  FITC-conjugated  streptavidin.  Negative  controls 
were perfomled with isotype-matched,  unrelated nkAbs.  For in- 
tracellular detection of Bcl-2 protein, cells were permeabilized by 
15-min incubation at 4~  in saponin (0.5  mg/ml) before staining. 
Fluorescence was analyzed on a FACScan  |  flow cytometer (Bec- 
ton Dickinson &  Co.).  Gating was set according to fbrward and 
right angle light scatter parameters to exclude subcellular particles 
from acquisition data. 
Giemsa Staining and Immunoenzymatic Staining of lg Light Chains. 
5  ￿  104  cells from each sorted population  were cytocentrifuged 
for 4 rain at 400 rpm on slides.  Some of these slides  were fixed in 
methanol for 1 min and stained with Giemsa solution (BDH Ltd., 
Poole, UK) diluted 1 : 10 in water for 10 n'fin.  For immunoenzy- 
matic stainings, some slides  were fixed in cold acetone at -20~ 
for 10 min, washed in PBS, and incubated for 30 rain with rabbit 
anti-K and anti-k mAbs (Dako), both diluted  1 : 40 in PBS.  After 
washing,  slides  were incubated with biotinylated goat anti-rabbit 
lg antibodies (Biosys)  diluted  1 : 100 in PBS for 30 rain,  washed, 
and  incubated  with alkaline phosphatase  coupled to  streptavidin 
(Biosource International Inc., Camarilla,  CA) at  1.5  mg/ml. Af- 
ter  washing,  enzymatic  activi  W  was  revealed with  fast  red  sub- 
strate (Dako), yielding a red precipitate. 
Preparation of Bone Alarrow Fibroblasts and Rheumatoid  Synavio- 
cytes.  Human femur fragments, obtained after informed consent 
of adult donors undergoing orthopedic hip surgeD,, were ditacer- 
ated to yield a BM cell suspension.  Characterization and isolation 
of BM  fibroblasts  was  previously  described  (16).  Briefly,  bone 
fraglnents  were decanted  and  cells subsequently  seeded in com- 
plete MEM for 7-10 d, and nonadherent cells were removed ev- 
ery 3 d. Cells of hematopoietic origin were then removed by ex- 
posure ofstromal cells to a cocktail of appropriate nLAbs followed 
by  depletion  with  immunomagnetic  beads  coated  with  anti- 
mouse lgG. Antibody-depleted stromal cells were seeded in 96- 
well plates and allowed to reach confluence, at which time stro- 
real cell layers were fibroblast-like cells with occasional adipocytes 
and were used for cocultures with sorted tonsillar cells. 
Synoviocytes  were  isolated  from  synovial  biopsies,  obtained 
from rheumatoid arthritis patients undergoing knee or wrist syn- 
ovectomy,  as  previously described  (17).  They  were  a  homoge- 
nous  population  of fibroblast-like  cells,  negative for the expres- 
sion of CD3,  CD19,  CD14,  and  HLA-DR, and positive for the 
expression of CD44,  CD10,  and  CD54,  as detemlined by flow 
cytometry analysis.  The  human  lung fibroblast  cell line  MRC5 
(American Type Culture Collection, Rockville, MD) was estab- 
lished from  14 week-old male fetuses, and has  been used widely 
as feeder cells to  transform  human  B  cells with EBV  (18).  This 
cell line expresses CD10. 
Cell  Cultures.  After  sorting,  cells  were  cultured  in  R.PMI 
1640  supplemented  with  10%  FCS  (GIBCO  BRL),  2  mM 
glutanfine,  100 U/ml penicillin, and 100 I,  tg/ml streptomycin (all 
from  Flow  Laboratories,  Inc.,  McLean,  VA).  The  final  volume 
was  100  ~.1 (2  ￿  104  cells/well of flat-bottomed 96-well plates) 
for viable cell counting,  lg production  assays, and  Giemsa stain- 
ings; and 500 ~.1 (2.5  ￿  10 s cells/well of 24-well plates)  for elec- 
tron microscopy and terminal deox~,nudeotidyl transferase  (TdT) 
assays.  Anti-CD40  (G28.5,  1  Ixg/ml)  or  SAC  particles  (0.05%) 
were added  at the onset of the culture.  For cocultures,  sorted B 
cells were  dispensed  on  confluent monolayers  of (a)  BM  fibro- 
blasts,  (b)  rheumatoid  synoviocytes.  (c)  lung  fibroblast  cell  line 
(MRCS), or (at) mouse L cells.  IgA, IgM, and lgG levels were de- 
termined  in supernatants  by  standard  ELISA techniques,  as  de- 
scribed earlier (19).  For viable cell recovery, cells were counted 
by trypan blue dye exclusion. In the case of the cocultures, B cells 
were easily distinguishable from fibroblasts by size. 
Electron Microscopy.  Cells were  harvested  and  pelleted in  2% 
glutaraldehyde  in culture medium and consecutively fixed in 2% 
glutaraldehyde-Na  cacodylate  HC1  0.1  M,  pH  7.4  (15  rain  at 
4~  After three washes  in Na  cacodylate HCI 0.1  M,  pH 7.4, 
sucrose 0.2 M  (15 min at 4~  cells were postfixed in OsO4  l%- 
Na cacodylate HC1 0.15 M, pH 7.4 (15  rain at 4~  dehydrated 
in a graded series of ethanols,  and embedded in Epon.  Ultrathin 
228  Bcl-2  + Human Plasma Cells Die from Apoptosis sections  (60-80  nm) were obtained with an uhramicrotome  (U1- 
tracut;  P,.eichert,  Vienna,  Austria)  contrasted  with  methanolic 
uranyl  acetate  and lead citrate,  and observed with a  transmission 
electron  microscope  (model  CM  120;  Philips  Technologies, 
Cheshire,  CT). 
TdT-mediated  dUTP-FITC  Nick  End  Labeling.  DNA  frag- 
mentation  in  apoptotic  cells  was  detected  according  to  the 
method described before  (20). Briefly,  5  ￿  10 s cells obtained im- 
mediately after sorting or after 4  h  of culture were fixed with 200 
txl  of PBS,  1%  paraformaldehyde,  for  10  min,  then  washed  in 
PBS  and  permeabilized  with  500  ~1  of 70%  ethanol  at  -20~ 
overnight￿9 After washing  with  PBS,  the  TdT-mediated  dUTP- 
FITC nick end labeling (TUNEL)  reaction was carried out by in- 
cubating cells at 37~  for 1  h  with 0.3  nmol  FITC-12-dUTP,  3 
nmol dATP,  2  Ixl 25 mM  CoC12,  25 U  TdT,  and TdT  buffer (30 
mM  Tris, pH 7.2,  140 mM  sodium cacodylate)  in a total reaction 
volume  of 50  pd  (all  reagents  from Boehringer  Mannheim  Bio- 
chemicals,  Indianapolis, IN).  The reaction was stopped by adding 
2  pd  0￿9  M  EDTA  for  10  min  at  4~  After washing  twice  in 
PBS,  1% BSA,  samples were  analyzed  by flow  cytometry.  Con- 
trol staining was performed  on  aliquots  of the  same  ceils treated 
with the staining mixture without TdT. 
Immunohistology.  Tonsil pieces were  snap frozen in liquid ni- 
trogen  and stored at  -70~  5-txm frozen sections were  cut and 
mounted  on  glass  slides.  They  were  dried  at  room  temperature 
and  fixed  in  cold  acetone  at  -20~  for  15  min.  Sections  were 
washed  in PBS  and were  incubated with peroxydase-conjugated 
anti-lgA  (4  mg/ml;  Southern  Biotechnology  Associates,  Bir- 
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Figure 1.  Isolation of the CD38hi~CD201~  tonsiltar PC. Total tonsillar cells obtained either directly after tonsil digestion (A) or after three centrifuga- 
tions over a 1.5% BSA solution (B) were stained with FITC-conjugated anti-CD20 (horizontal  axis,  log scale) and PE-conjugated anti-CD38 mAbs (vertical 
axis,  log scale).  CD38highCD20 l~  PC (C), CD381~  m~dium resting B cells  (D), and CD38mediumCD20high GC B cells  (E) were sorted with a FACStar 
plus  |  Numbers indicate the percentages of cells obtained in the corresponding in~et (mean -+ SEM of seven independent experiments). 
229  Merville et al. mingham, AL) and unconjugated mouse  anti-CD38  mAb  (Im- 
munotech) diluted 1 : 100 in PBS. After washes, slides were incu- 
bated with sheep  anti-mouse Ig (Binding Site)  diluted 1:20  in 
PBS containing 10% human serum. Slides were then washed and 
incubated with mouse mAbs against alkaline phosphatase and al- 
kaline  phosphatase  complexes  (APAAP;  Dako).  After  a  final 
wash, peroxidase was developed with 3-amino-9-ethylcarbazole, 
which gives a red color, and alkaline phosphatase was developed 
by fast blue substrate,  which gives a blue color. 
of tonsillar B  cells express slgG but not slgA (10).  Never- 
theless,  the  isotype distribution in  the  culture  supernatant 
correlated with that obtained after intracytoplasmic staining 
of sorted PC  (data not  shown).  Furthermore,  double  ira- 
Results 
The CD38 high CD2ff ~  Fraction of Tonsillar  Cells Represents 
Terminally Differentiated PC.  Previous studies have charac- 
terized  human  PC  as  CD38 high- and  CD201~ 
cells (11,  13). Cells with this phenotype were found to rep- 
resent  only  1-2%  of tonsillar cells  (Fig.  1 A).  Centrifuga- 
tions of the tonsil cell suspension over a  1.5% BSA solution 
at 10 g permitted us to enrich CD38highCD20 l~  cells up to 
"-~8%  (Fig.  1  /3).  This  enrichment  step  subsequently  al- 
lowed us to isolate CD38highCD20 l~  cells by FACS  |  sort- 
ing (Fig.  1  C). From the same tonsillar preparation (Fig. 1, 
D  and E),  CD38mediumCD20 high GC B  cells and CD381  .... 
CD20medi  ....  resting B  cells  (8,  9)  were  also  collected and 
analyzed in parallel with PC. 
After Giemsa  staining,  CD38highCD20 l~  cells display a 
typical PC  morphology,  including an  eccentric nucleus,  a 
dark basophilic cytoplasm, and  a  pale  Golgi compartment 
(Fig. 2  A).  In accordance with the morphological features 
of PC,  immunoenzymatic staining with anti-IgK and anti- 
Ig~.  antibodies  showed  that  the  sorted  CD38highCD20 ~~ 
cells contained high levels of intracytoplasmic Igs (Fig. 2  B), 
in contrast to GC B  cells and resting B  cells (data not shown). 
Electron  microscopic  study  of  sorted  CD38highCD20 l~ 
cells  reveals  ultrastructural  characteristics  of PC  showing 
parallel arrays  of rough  endoplasmic  reticulum,  a  distinct 
juxtanuclear Golgi area, and many mitochondrias (Fig. 2  C). 
CD38h'~hCD2ff ~  Tonsillar  Plasma  Cells  Have  a  Distinct 
Surface Phenotype.  To determine tonsillar PC surface phe- 
notype, these cells were sorted according to their very high 
expression of CD38  (fluorescence intensity above log 103, 
Fig.  1)  and  were  further  stained  with  FITC-conjugated 
rnAbs.  PC  expressed B  cell markers such  as CD9,  CD19, 
CD24,  CD37,  CD40,  CD74,  and  HLA-DR,  but  did not 
express CD10  nor HLA-DQ  (Fig. 3).  By contrast to plas- 
rnacytoma  cells  (21)  and  myeloma  cells  (22),  CD28  and 
CD56 were not detectable on tonsillar PC.  The absence of 
CD3 +  and  CD14 +  cells confirmed the lack of T  cells and 
rnonocytes in the PC population. 
Human  Tonsils  Contain  Many  IgA-secreting  PC beneath  the 
Mucosal Epithelium.  To  functionally prove that the sorted 
CD38highCD20 l~  cells are PC, they were cultured for 12 h, 
and the spontaneous Ig secretion into culture medium was 
measured  by ELISA.  As  shown  in  Fig.  4,  only PC  were 
able to produce significant amounts oflgA (mean -+ SEM = 
214  -+  37  ng/ml,  n  =  3)  and IgG (293  -+  89  ng/ml),  but 
low levels of IgM (29  _+  9  ng/ml).  The  comparable levels 
of secreted IgG and IgA were surprising since the majority 
Figure 2.  The CD38highCD201~  tonsillar cells have morphological fea- 
tures  of PC  and  contain  high  levels of Ig.  (A)  Giemsa staining of 
CD38highCD20  l~  tonsillar PC displaying  an eccentric nucleus, a dark ba- 
sophilic cytoplasm, and a pale Golgi compartment.  X 1,000. (/3) lmmu- 
noenzymatic red staining with anti-K and anti-X antibodies showing that 
CD38highCD201~  PC contain high levels of Ig. X 1,000. (C) Electron mi- 
croscopic observation of a CD38highCD201~  PC showing parallel arrays 
of endoplasmic reticulum. ￿  11,800. 
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Figure  3.  Surface phenotype 
of tonsillar PC. The surface phe- 
notype of  PC isolated by FACS  | 
sorting according to  their high 
CD38  expression (stained with 
anti-CD38-PE) was analyzed by 
FITC-labeled mouse mAbs. His- 
tograms corresponding to  each 
mAb (solid  line) are superimposed 
on that of the  isotype-matched 
unrelated  mAb  (dashed line). 
Horizontal and vertical axes il- 
lustrate log of fluorescence and 
relative  cell numbers,  respec- 
tively. 
munohistological staining of tonsil  sections with  red  anti- 
IgA and blue anti-CD38 further confirmed that ~40-50% 
of tonsillar  CD38  high PC  contained  intracellular  IgA (Fig. 
5).  Whereas  most  IgA  +  PC  (dark purple)  were  found be- 
neath the mucosal epithelium (Fig. 5 A) and occasionally in 
the  interfollicular  areas  (not  shown),  CD38  high PC  (dark 
blue) found in GC were IgA- (Fig. 5 B). The biological sig- 
nificance of such an anatomical distribution  of PC in rela- 
tion to their life span and survival is discussed later. 
Wonsillar PC  Die  Rapidly  by  Apoptosis  During  In  Vitro 
Culture.  During our attempts to estimate  survival of nor- 
mal  PC,  we  found that  they died  very rapidly  in  culture 
medium at 37~  As shown in Fig. 6, PC lost their viability 
400. 
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￿9  lgG 
[]  IgM 
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0' 
Resting B cells  GC B cells  Plasma cells 
Figure  4.  Tonsillar PC mainly release IgG and IgA. 2 ￿  104 sorted 
resting B cells, GC B cells, and PC were cultured in medium alone for 12 h, 
and IgA, IgM, and IgG levels were measured in supernatants by ELISA. 
Results are expressed as mean +~ SEM of three separate experiments. 
even more rapidly than did GC B  cells,  since only 22% of 
viable PC were recovered after 6 h  and <5% after 24 h  of 
culture.  As  expected  (23),  >60%  of resting  B  cells  re- 
mained viable  after  24  h  of culture.  After 4  h  of culture, 
numerous  PC  displayed  apoptotic  figures,  with  typical 
chromatin  condensation  and nuclear fragmentation,  as re- 
vealed by Giemsa staining (Fig.  7 A) and electron micros- 
copy (Fig.  7  B).  The  presence  of parallel  arrays  of rough 
endoplasmic reticulum within the cytoplasm indicated that 
the apoptotic cells indeed derived from PC  (Fig. 7  /3). To 
provide molecular  evidence  that  PC  undergo  apoptosis,  a 
TUNEL  method  was  used  to  detect  DNA  fragmentation 
(20). As shown in Fig. 8, only a small proportion of freshly 
sorted  cells  including  resting B  cells,  GC B  cells,  and PC 
were labeled by dUTP-FITC.  Strikingly, after only 4 h  of 
culture,  the  majority  of  GC  B  cells  (66.7%)  and  PC 
(80.3%) were labeled by dUTP-FITC, whereas only 12.2% 
of resting B  ceils were labeled. 
Tonsillar PC Express Bcl-2 but Not Fas/CD95.  The Bcl-2 
gene product (24)  and Fas/CD95  (25, 26) have been docu- 
mented as playing important roles in the regulation of cell 
survival and death. Since the rapid onset of apoptosis in GC 
B  cells  correlates  with  their  low  expression  of Bcl-2  (27) 
and high expression  of Fas/CD95  (10,  28),  the  expression 
ofintracellular Bcl-2 and surface Fas/CD95 was assessed by 
flow cytometry in PC in parallel  with  that  of GC B  cells 
and resting B  cells.  Interestingly,  a large proportion of PC 
expressed  Bcl-2  without  displaying  Fas/CD95  (Fig.  9),  a 
finding apparently in contrast with their propensity to rap- 
idly enter apoptosis. 
231  Merville et al. Figure 5.  Anatomical  localization  of tonsillar  IgA  + PC and IgA- PC. 
Tonsil sections were double stained with red anti-IgA and blue anti- 
CD38. (A)  many double stained (dark purple) IgA+CD38  ++  PC  were 
found within the fibroblast  networks beneath the basal mucosal epithelial 
cells. (/3) the PC cells within a GC of the same section contain many  sin- 
gle-stained (dark blue) IgA-CD38  ++ presumptive  PC. ￿  100. 
Plasma Cells Are Rescued  from Apoptosis  by Contact with BM 
Fibroblasts but  Not  by  Antigen  Receptor  or  CD40  Triggering. 
Table  1  shows  that  SAC  particles  and  anti-CD40  mAb, 
which markedly enhance the viability of GC B  cells (23), 
are unable to sustain PC viability. Similarly, CD40 ligand- 
transfected  L  cells,  anti-Ig antibodies,  and  cytokines  in- 
80 
60-  Resting B cells 
40- 
20-  -  ~-,.,,~  "'~  GC B cells 
PC  0 
0  3  6  12  24 
Time of culture after sorting (h) 
Figure  6.  Tonsillar PC  die  rapidly in  culture.  2  ￿  104  sorted  resting 
GC B  cells and PC were cultured in medium alone for 24 h.  Percentage 
of viable cells was determined at various time points by trypan blue dye 
exclusion. Results are expressed as mean --- SD of culture triplicates. 
Figure  7.  The dead PC show apoptotic figures. 2 ￿  10  ~ tonsillar  PC 
were cultured for 4 h in culture medium. (A) Giemsa staining  showing 
apoptotic PC with nuclear condensation  and fragmentation. ￿  1,000. (/3) 
An apoptotic PC with chromatin condensation  shows arrays of rough en- 
doplasmic reticulum under the electron microscope. ￿  11,800. 
volved in B  cell activation (IL-2,  IL-3,  IL-4,  IL-10,  and 
TNF-ot) were unable to maintain the viability of PC  (data 
not shown). In addition, IL-6 at a concentration up to 250 
ng/inl  did not prevent PC death (Table 2). Together with 
the different patterns of Bcl-2 and Fas/CD95 expression of 
GC B  cells and PC,  these results indicate that the apopto- 
sis/survival of both cell types is regulated through different 
mechanisms. 
In vivo experiments, however,  have shown that a  pro- 
portion of PC  generated within the  secondary lymphoid 
organs migrates into BM (29)  or lamina propria of the mu- 
cosa,  where  they survive for  3  wk  (5).  This suggests  that 
survival signals  for  PC  may  be  dependent  on  these  mi- 
croenvironments. In accordance with this hypothesis, puri- 
fied human BM fibroblasts greatly improved the viability of 
cultured plasma cells (82.7% on fibroblasts vs.  16.3% in me- 
dium alone, Table 1) as well as GC B  cells (89.5% of viable 
cells on fibroblasts vs.  27.5%  in medium alone,  Table  1). 
Since the inflammatory rheumatoid synovium is an ectopic 
site  for  PC  accumulation  (30),  synovial fibroblasts  (syn- 
oviocytes)  were  compared  with  BM  fibroblasts  for  their 
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Figure  8.  Detection  of  DNA 
fragmentation  within apoptotic  PC. 
PC,  GC B cells, and resting B cells 
isolated from the same tonsils were 
cultured  for 4 h in culture  medium. 
The  DNA  fragmentation  within 
these  cells  was  analyzed  by  the 
TUNEL method (see Materials and 
Methods)  before  and  after  4  h  of 
culture.  The maximal  dUTP-FITC 
labeling of cells without TdT reac- 
tion are indicated by the dotted lines 
as negative  controls.  Horizontal and 
vertical axes illustrate log of fluores- 
cence and  relative  cell number,  re- 
spectively. Data shown are from one 
representative of three experiments. 
ability  to  maintain  PC  survival.  Table  1  also  shows  that 
synoviocytes were  able  to  potently  rescue  GC  B  cells and 
PC from apoptosis.  The maintainance  of PC survival by fi- 
broblasts  was  dependent  upon  cell-cell contact,  since  PC 
died rapidly when  separated  from fibroblasts by a  semiper- 
meable membrane  (data not shown). 
To  further  investigate  if the  fibroblast-dependent  PC 
survival is specific to BM  and synovial fibroblasts,  PC were 
also cultured on a monolayer of human lung fibroblasts or a 
monolayer of murine  fibroblasts  (L cells) for 12 h.  Table  1 
shows that human lung fibroblasts significantly enhance the 
viability of both PC and GC B  cells, whereas the murine L 
cell line did not.  The  survival effect of human  lung fibro- 
blasts  on PC  is,  however,  always lower than  that  of either 
BM  fibroblasts or synoviocytes. 
In contrast with the recent study showing that  IL-6 pro- 
tects human  BM  PC  from apoptosis  (31),  IL-6 and a  wide 
range of cytokines used in the present study (IL2,  IL3, IL4, 
ILl0,  TNF-o 0  did not protect tonsillar PC from apoptosis. 
To  further  investigate  if fibroblast-dependent  PC  survival 
was mediated by IL-6 released by fibroblasts during a  close 
cell-cell interaction,  functional blocking antibodies  against 
the  IL-6  receptor  gp80  chain  were  added  into  the  cocul- 
ture of PC and fibroblasts.  Table 2  shows that anti-IL-6 re- 
(Resting B cells)  (GC B cells)  Plasma cells) 
BCL2 
Fas/CD95  [ 
t  .....  ￿9  ..... ￿9  - ;,;-al 
10  10  2  10 3  I0  10  2  10  3  ..... ;o  ....  m~ '"'?o3 
Figure 9.  Tonsillar PC express intracytoplasmic Bcl-2 
but not surface Fas/CD95. PC, GC B cells, and resting B 
cells were stained with FITC-conjugated anti-Fas/CD95 
mAb  or  with  FITC-conjugated  anti-Bcl-2  mAb  after 
permeabihzation  of the  cells with saponin.  Histograms 
corresponding  to each mAb (solid  line)  are superimposed 
on that  of the negative  control (dashed  line)  performed 
with an isotype-matched  unrelated mAb. Horizontal and 
vertical axes illustrate log of fluorescence and relative cell 
number,  respectively. 
233  Merville et al. Table 1.  PC Are Rescued  from Apoptosis by Fibroblasts 
Percentage of viable cells 
Resting B Cells  GC B cells  PC 
Medium  81.6 --- 3.8  27.5  +  0.5  16.3  Z  0.5 
SAC  70.2  _+  10.9  45.3  _+ 5.2  17.7  _+  1.0 
Anti-CD40  74.3  _+ 6.2  44.2  +  5.9  17.2 _+ 0.2 
BM fibroblasts  97.4 +  0.9  89.5  +  0.7  82.7  -+ 5.3 
Synoviocytes  97.2  +  0.7  72.5  -+ 12.2  63.4  +  8.6 
Murine fibroblasts  ND  31.2 +  2.6  21.6  +_  1.1 
Lung fibroblasts  ND  76.4 ___  1.7  51.6  •  0.3 
2 x  104 resting B cells, GC B cells, or PC were cultured in medium 
alone for 12 h or in the presence of SAC particles (0.05%), anti-CD40 
mAbs (G28.5, 5 I,  tg/ml), and/or a monolayer offibroblasts. Percentages 
of viable ceils  were determined by trypan blue dye exclusion. 
*Mean +  SEM of three experiments. 
ceptor  antibodies  did  not  block  the  fibroblast-dependent 
PC  survival,  suggesting  that  human  tonsillar PC  may  be 
different from BM PC in terms of IL-6-mediated survival. 
Discussion 
Differentiation of B  lymphocytes into PC mostly occurs 
within secondary lymphoid organs, where they represent a 
minor population compared with  naive  B  cells or  GC  B 
cells.  Thus,  our  knowledge  about  PC  is  mainly  derived 
from the phenotypic and functional studies of PC  tumors, 
such as myelomas and plasmacytomas. Herein, we designed 
a  procedure  to  purify  PC  from  human  tonsils  by  sorting 
CD38highCD201~  cells after enrichment  by repeated cen- 
trifugations through a BSA gradient. 
Surface  phenotypic analysis shows  that  tonsillar PC  ex- 
press several pan-B cell markers such as CD19,  CD37,  and 
Table 2.  The Fibroblast-dependent Plasma Cell Sun,ival Is 
Independent of lL-6 
Percentage of viable cells 
PC  GC 
Plastic 
Medium  23.6 +  2.9  44.4  _+ 3.7 
IL-6  27.3  -4- 0.2  44.2  _+ 0.1 
Synoviocytes 
Medium  76.5  +- 3.8  86.8  -  2.2 
Anti-IL-6 R.  70.5  +  4.1  ND 
Culture  conditions are described in the legend for Table  1. IL-6 was 
used at a final concentration  of 40 ng/ml. Anti-lL-6 receptor gp80 an- 
tibody BI<6 was used at 10 l.tg/ml. Data shown are from one represen- 
tative of two independent experiments. 
CD40.  The expression of CD19  on PC  is in contrast with 
the reported lack of CD19 on myeloma and plasmacytoma 
cell lines,  which  had  led to  a  conclusion  that  normal  PC 
may not express CD19  (32).  CD19,  however, was also re- 
cently found on normal PC isolated from BM (22, 33) and 
on those generated in vitro (17, 34).  Thus,  normal PC can 
be distinguished from malignant PC by their expression of 
CD19.  In the same line,  CD28  is expressed on plasmacy- 
toma (21)  and myeloma cells (33),  but not on normal PC. 
Accordingly, CD28  may represent  a  potential marker  for 
diagnosis of malignant PC tumors, and its function on ma- 
lignant  PC  remains  to  be  established.  The  expression  of 
CD40 antigen on tonsillar PC complements the similar ob- 
servation  on  BM  PC  (33)  and  myeloma  cells  (35).  The 
function of CD40 antigen on PC remains to be determined 
as its ligation failed to rescue them from apoptosis (36). 
A  major finding of this study is the propensity of PC  to 
undergo  spontaneous  apoptosis. The  molecular regulation 
of PC apoptosis/survival appears different from that of GC 
B  cells. First, PC express the intracytoplasmic Bcl-2 protein 
at a level comparable to that of resting B  cells, whereas GC 
do  not.  The spontaneous  apoptosis of Bcl-2 +  PC  suggests 
that other survival/death genes may be involved (25).  The 
Bcl-2  gene  family presently contains  at  least  seven  genes 
(37),  which  represent control elements  of the  first check- 
point of apoptosis (38).  A  second checkpoint  of apoptosis 
has  recently been identified which  is controlled by mem- 
bers of the IL-1]3-converting enzyme gene family, includ- 
ing ICE,  ICH-1,  and CPP32  (38-40).  It will therefore be 
interesting to  determine  the  expression of these  genes  in 
PC either undergoing apoptosis or being rescued by fibro- 
blasts. Second, the surface triggers involved in PC apopto- 
sis/survival are obviously different from that of GC B  cells. 
In contrast to  GC  B  cells, PC  do  not express surface Fas/ 
CD95, which triggering has been shown to induce apopto- 
sis of activated B  cells and  T  cells (41-43)  and  accelerate 
spontaneous apoptosis ofGC  B cells (10). Signals known to 
rescue  GC  from  apoptosis,  such  as  antigen  receptor  and 
CD40  triggering,  had  no  effect  on  PC.  However,  direct 
contact of PC with BM or synovial fibroblasts represents an 
efficient survival signal for these cells. Interestingly, human 
lung fibroblasts, which are efficient to maintain GC  B  cell 
survival (44), were able to enhance PC survival to a limited 
extent. In addition, IgA  + PC were found mostly within the 
connective  tissue  beneath  the  mucosa  (Fig.  5).  All  these 
data suggest that fibroblasts and/or stromal cells may pro- 
vide  the  microenvironments  beneath  the  mucosa,  within 
the BM  and  the  rheumatoid synovium,  that  are favorable 
for the survival of plasma cells (45, 46). 
This  finding is in accordance with  a  number  of studies 
showing  that  GC  B  cells,  peritoneal B  cells,  thymocytes, 
and T  cells can be protected from rapid apoptosis by stro- 
real cells or fibroblasts (18,  44,  47,  48).  Although the mo- 
lecular mechanism  of stroma/fibroblast-mediated cell sur- 
vival  is  currently  unknown,  these  data  suggest  that  PC 
survival depends on direct cell-cell contact, but not on cy- 
tokines such as IL-2, IL-3, IL-4, IL-6, IL-10, and TNF-ot. 
In conclusion, we have isolated normal tonsillar PC that 
234  Bcl-2  + Human Plasma Cells Die from Apoptosis display a rapid onset of apoptosis and a unique regulation of 
apoptosis/survival. Analysis of the surface and intracellular 
molecules that  control PC  survival may ultimately permit 
us to understand the pathogenesis of myeloma and plasma- 
cytoma. 
We thank J. R.eyes and E. Garcia for FACS  |  sorting, I. Berger for preparation of ultrathin sections, G. Joly 
for ultrastructural pictures, S. Peyrol for expert help with electron  microscopy, C. Van Kooten for CD40 
ligand-transfected L cells, F. Bri~re and C. Arpin for helpful discussions, and N. Courbi6re and M. Vatan for 
editorial assistance. 
P. Merville andJ. D&hanet are the recipients of a grant from the Fondation M&ieux (Lyon, France). 
Address correspondence  to Y. J. Liu, Schering-Plough  Laboratory for Immunological  Research, 27 Chemin 
des Peupliers, B.P. 11, 69571 Dardilly Cedex, France. The present address for P. Merville andJ. D&hanet is 
CNRS URA 1456, Universit~ Bordeaux II, 33076, Bordeaux, France. 
Received  for publication  IOJuly  1995 and in revised form 2I August  1995. 
References 
1. Jerne, N.K. 1984. Idiotypic networks and other preconceived 
ideas. Immunol. Rev. 79:5-24. 
2. Jerne, N.K.  1989. Opening speech  for the 7th International 
Congress  of Immunology. In Progress  in  Immunology. F. 
Nelchers et al., editors.  Springer-Verlag.  Berlin. 7:XXXIII- 
XXXIV. 
3. Banchereau, J.,  and F.  Rousset.  1992. Human B  lympho- 
cytes: phenotype, proliferation and differentiation.  Adv.  lm- 
munol. 52:125-251. 
4.  Kosco, M.H., A.K. Szakal, andJ.G. Tew.  1988. In vivo ob- 
tained antigen presented by germinal center B cells to T cells 
in vitro../, lmmunol.  140:354-360. 
5.  Ho, F.,J.E. Lortan,  I.C.M. MacLennan, and M. Khan. 1986. 
Distinct short-lived and long-lived antibody-producing cell 
populations. Eur. J. Immunol.  16:1297-1301. 
6.  M~ikel~i, O., and G.J.V. Nossal. 1962. Autoradiographic stud- 
ies on the immune response.  II. DNA synthesis among single 
antibody-producing  cells.J.  Exp. Med.  115:231-244. 
7.  Benner, R., W. Hijmans, andJ.J. Haaijman. 1981. The bone 
marrow:  the  major source  of serum immunoglohulins, but 
still a neglected site of antibody formation. Clin.  Exp.  lmm,~- 
nol. 46:1-8. 
8.  Pascual,  V.,  Y.-J.  Liu,  A.  Magalski,  O.  de  Bouteiller, J. 
Banchereau, andJ.D. Capra.  1994. Analysis of somatic muta- 
tion in five B cell subsets of human tonsil.J. Exp. Med.  180: 
329-339. 
9.  Liu,  Y.-J.,  O.  de  Bouteiller,  C.  Arpin,  I.  Durand,  and J. 
Banchereau.  1994. Five human mature B cell subsets, b~ In 
Vivo  Immunology. E.  Heinen, M.P.  Defresne,  J.  Boniver, 
and V. Geenen, editors. Plenum Press, New York.  289-294. 
10. Liu, Y.-J.,  C. Barthelemy,  O. de Bouteiller,  C. Arpin, I. Du- 
rand, and J. Banchereau.  1995. Memory B cells from human 
tonsils colonize mucosal epithelium and directly present anti- 
gen to T cells by rapid upregulation of B7.1 and B7.2. bnmu- 
nity. 2:238-248. 
11. Stashenko,  P., L.M.  Nadler, P,. Hardy,  and S.F. Schlossman. 
1981. Expression  of cell surface markers after human B lym- 
phocyte  activation.  Proc. Natl.  Acad. Sci. USA.  78:3848- 
3852. 
12. Anderson,  K.C.,  M.P.  Bates, B.L.  Slaughenhoupt,  G.S. 
Pinkus, S.F. Schlossman, and L.M.  Nadler.  1984. Expression 
235  Merville et al. 
of human B cell-associated  antigens on leukemias  and lym- 
phomas:  a model of human B cell differentiation.  Blood. 63: 
1424-1433. 
13. Ling, N.R., I.C.M. MacLennan, and D. Mason.  1987. B-cell 
and plasma cell antigens: new and previously defined clusters. 
In  Leucotype  Typing IIl.  A.J. McMichael,  editor.  Oxford 
University Press. Oxford, UK. 302-335. 
14. Vail6, A., C.E. Zuber, T. Defrance,  O. Djossou, M. De Rie, 
and J.  Banchereau.  1989. Activation of human B  lympho- 
cytes through CD40 and interleukin 4.  Eur. J.  lmmunol.  19: 
1463-1467. 
15. Clark, E.A., andJ.A. Ledbetter.  1986. Activation of human B 
cells mediated through two distinct cell surface differentiation 
antigens,  Bp35  and Bp50.  Proc. Natl.  Acad. Sci. USA.  83: 
4494-4498. 
16. Moreau, I., V. Duvert, C. Caux, M.-C. Galmiche, P. Char- 
bord, J.  Banchereau, and S.  Saeland.  1993. Myofibroblastic 
stromal  cells isolated  from human bone marrow induce the 
proliferation of both  early  myeloid and B  lymphoid cells. 
Blood. 82:2396-2405. 
17. Dechanet, J.,  P.  Merville,  I.  Durand, J.  Banchereau, and P. 
Miossec.  1995. The ability ofsynoviocytes to support termi- 
nal differentiation of activated B cells may explain plasma cell 
accumulation in rheumatoid synovium. J.  Clin.  Invest. 95: 
456-463. 
18. Gregory,  C.D., C.F. Edwards, A. Milner, J. Wiels, M. Lipin- 
ski, M. Rowe, T. Tursz, and A.B. Rickinson. 1988. Isolation 
of a normal B cell subset with a Burkitt-like phenotype and 
transfomlation in  vitro by Epstein-Barr virus.  Int. J.  Cancer. 
42:213-220. 
19. Defrance,  T., B. Vanbervliet, J.P. Aubry, andJ. Banchereau. 
1988. [nterleukin 4 inhibits the proliferation but not the dif- 
ferentiation of activated  human B cells in response  to inter- 
leukin 2.J. Exp. Med.  168:1321-1337. 
20. Sgonc,  R.,  G. Boeck,  H.  Dietrich, J.  Gruber, H.  Recheis, 
and G. Wick.  1994. Simultaneous detemlination of cell sur- 
face antigens and apoptosis.  Trends Genet.  10:37-67. 
21. Kozbor,  D.,  A.  Moretta,  H.A.  Messner,  L.  Moretta,  and 
C.M.  Croce.  1987.  Tp44  molecules involved in  antigen- 
independent T cell activation are expressed on human plasma 
cells.J. Immunol. 138:4128-4132. 22. Harada, H., M.M. Kawano, N. Huang, Y. Harada, K. Iwato, 
O.  Tanabe, H.  Tanaka,  A.  Sakai, and A.  Kuramoto.  1993. 
Phenoty.  pic  difference  of normal plasma  cells  from  mature 
myeloma cells. Blood. 8l:2658-2663. 
23. Liu, Y.J.,  D.E. Joshua,  G.T. Williams, C.A.  Smith, J.  Gor- 
don, and I.C.M. MacLennan. 1989. Mechanisms of antigen- 
driven selection in germinal centers. Nature (Lx}nd.). 342:929- 
931. 
24. Reed, J.C.  1994. Mini-review: cellular mechanisms of disease 
series.  Bcl-2 and the regulation of programmed cell death./. 
Cell Biol. 124:1-6. 
25. Korsmeyer,  S.J.,  J.R.  Shutter,  D.J.  Veis,  D.E.  Merry,  and 
Z.N.  Oltvai.  1993.  bcl-2 protein expression is widespread in 
the developing nervous system and retained in the adult PNS. 
Senlin.  Cancer Biol. 4:327-332. 
26. Nagata, S.,  and T. Suda.  1995. Fas and Fas ligand: lpr andgld 
mutations. Immunol.  Today.  16:39-43. 
27. Liu, Y.-J., D.Y. Mason, G.D. Johnson, S. Abbot, C.D. Gre- 
gory, D.L. Hardie, J. Gordon, and I.C.M. MacLennan. 1991. 
Germinal center cells express bd-2 protein after activation by 
signals which prevent their entD' into apoptosis. Eur. J. lmmu- 
nol. 21:1905-1910. 
28. M6ller,  P.,  C.  Henne,  F.  Leith~iuser,  A.  Eichelmann,  A. 
Schmidt, S. Brfderlein, J.  Dhein, and P.H. Krammer.  1993. 
Coregulation of the APO-1  antigen with intercellular adhe- 
sion molecule-1  (CD54)  in tonsillar B  cells  and coordinate 
expression in follicular center B cells and in follicle center and 
mediastinal B-cell lymphomas. Blood. 81:2067-2075. 
29. Tew, J.G.,  R.-M.  DiLosa,  G.F.  Burton,  M.H.  Kosco,  L.I. 
Kupp, A. Masuda, and A.K. Szakal.  1992.  Germinal centers 
and  antibody production  in  bone  marrow,  hnmunol.  Re1,. 
126:99-112. 
30. Kurosaka,  M.,  and M.  Ziff.  1983.  Inmmnoelectron micro- 
scopic study of the distribution of T  cell subsets in rheuma- 
toid synovium..]. Exp. Med.  158:1191-1210. 
31. Kawano, M.M., K. Mihara, N. Huang, T. Tsujimoto, and A. 
Kuramoto.  1995.  Differentiation  of  early  plasma  cells  on 
bone marrow stromal cells requires interleukin-6 for escaping 
fiom apoptosis. Blood. 85:487-494. 
32. Nadler, L.M., K.C. Anderson, G. Marti, M. Baytes, E. Park, 
J.F.  Daley, and S.F. Schlossman. 1983. B4, a human B  lynx- 
phocyte-associated antigen expressed on nomaal, mitogen ac- 
tivated, and malignant B lymphocytes..], lmmunol.  131:244- 
250. 
33. Pellat-Deceunynck,  C.,  R.  Bataille,  N.  Robillard,  J.-L. 
Harousseau,  M.-J.  Rapp,  N.  Juge-Morineau, J.  Wijdenes, 
and M. Amioc 1994. Expression of CD28 and CD40 in hu- 
man myeloma cells: a comparative study with normal plasma 
cells. Blood. 84:2597-2603. 
34. Merville,  P.,  J.  Dechanet,  G.  Grouard,  I.  Durand,  and J. 
Banchereau.  1995.  T  cell-induced B  cell blasts  differentiate 
into plasma cells when cultured on bone marrow stroma with 
IL3 and ILl0. Int.  hnmunol.  7:635-643. 
35. Westendorf, J.J.,  G.J. Ahmann, R.J. Armitage, M.K. Spriggs, 
J.A.  Lust,  P.R.  Greipp, J.A.  Katzmann,  and  D.F. Jelinek. 
1994.  CD40  expression m  malignant plasma  cells.  Role  in 
stimulation of autocrine IL-6 secretion by a human myeloma 
cell line. J.  hnm,mol.  152:117-128. 
36. Banchereau, J.,  F. Bazan, D. Blanchard, F. Brihre, J.-P. Gal- 
izzi,  C.  van Kooten, Y.-J.  Liu,  F.  Rousset,  and S.  Saeland. 
1994.  The CD40 antigen and its ligand. ,~lnnu. Rev. Immunol. 
12:881-922. 
37. Nunez, G., and M.F. Clarke. 1994. The Bcl-2 family of pro- 
teins: regulators of cell death and survival. Trends  Cell.  Biol. 
4:399-404. 
38. Oltvai, Z.N., and S.J. Korsmeyer.  1994. Checkpoints of du- 
eling dimers foil death wishes. Cell. 79:189-192. 
39. Wang,  L.,  M.  Miura,  L.  Bergeron,  H.  Zhu,  and J.  Yuan. 
1994.  Ich-1, and Ice/ced-3-related gene, encodes both posi- 
tive and negative regulators of programmed cell death.  Cell. 
78:739-750. 
40.  Fernandes-Alnemri, T., G. Litwack, and E.S. Alnemri. 1994. 
CPP32,  a novel human apoptotic protein with homology, to 
Caenorhabditis elegans cell death protein Ced-3 and mamma- 
lian interleukin-l~3-converting enzyme..].  Biol. Chem.  269: 
30761-30764. 
41. Trauth, B.C., C. Klas, A.M. Peters, S. Matzku, P. Moler, W. 
Falk, K.M.  Debatin, and P.H.  Krammer.  1989.  Monoclonal 
antibody-mediated tumor regression by induction of apopto- 
sis. Science (H/ash. DC). 245:301-305. 
42. Garrone, P., E.M.  Neidhardt, E. Garcia, L.  Galibert, C.  van 
Kooten, andJ. Banchereau.  1995. Fas ligation induces apop- 
tosis of CD40-activated human B  lymphocytes.d. Exp. Med. 
182:1265-1273. 
43. Lagresle,  C., C. Bella, T. Daniel, P.H. Krammer, and T. De- 
france.  1995.  Regulation ofgemfinal center B cell differenti- 
ation. Role  of the human APO-1/Fas  (CD95)  molecule, d. 
Immunol.  154:5746-5756. 
44. Holder,  M.J.,  Y.-J.  Liu,  T.  Defiance,  L.  Flores-Romo, 
I.C.M. MacLennan, andJ. Gordon.  1991.  Growth factor re- 
quirements for the stimulation of germinal center B cells: ev- 
idence for an interleukin 2-dependent pathway of develop- 
ment. Int.  lmmunol.  3:1243-1251. 
45. Dilosa,  R.M.,  K.  Maeda,  A.  Masuda,  A.K.  Szakal,  and J.G. 
Tew. 1991. Genninal center B cells and antibody production 
in the bone inarrow.J, hnmunol.  146:4071-4077. 
46. Hibi, T., and H.-M. Dosch.  1986.  Limiting dilution analysis 
of the B  cell compartment in human bone marrow.  Eur. J. 
lmmuno[.  16:139-145. 
47. Hardin, J.A., K. Yamagnchi, and D.H. Sherr.  1995.  The role 
of peritoneal stromal cells in the survival ofslgM + peritoneal 
B lymphocyte populations. Cell.  hmnunol.  161:50-60. 
48. Scott, S., F. Pandolfi, andJ.T. Kurnick. 1990. Fibroblasts me- 
diate T  cell survival: a proposed mechanism for retention of 
primed T  cells.J. Exp. Med.  172:1873-1876. 
236  Bcl-2 § Human Plasma Cells Die from Apoptosis 